These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34641776)

  • 1. Management of Urological Malignancy in Heart and Lung Transplant Recipients: An Irish National Cohort Study.
    Keenan RA; Haroon U; Ryan P; Harrington B; Jones A; Aboelmagd M; Connolly S; O'Mally KJ; Galvin D; Hegarty N
    Exp Clin Transplant; 2021 Oct; 19(10):1069-1075. PubMed ID: 34641776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of urologic de novo malignancies after renal transplantation.
    Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
    Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study.
    Lu K; Chiu KY
    Clin Transplant; 2023 Oct; 37(10):e15047. PubMed ID: 37306943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urological tumors in renal transplantation.
    Tillou X; Doerfler A
    Minerva Urol Nefrol; 2014 Mar; 66(1):57-67. PubMed ID: 24721941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
    Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
    Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De Novo Urological Malignancies After Renal Transplantation: An Asian 30-Year Experience.
    Lee HJ; Lim EJ; Woo SJQ; Aslim EJ; Ng LG; Gan VHL
    Clin Transplant; 2024 Jul; 38(7):e15415. PubMed ID: 39049619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitional cell carcinoma in renal transplant recipients: a single center experience.
    Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
    Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study.
    Palazzetti A; Bosio A; Dalmasso E; Destefanis P; Fop F; Pisano F; Segoloni G; Biancone L; Volpe A; Di Domenico A; Terrone C; Iesari S; Famulari A; Todeschini P; Frea B; Gontero P
    Urol Int; 2018; 100(2):185-192. PubMed ID: 29342465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
    Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
    Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Urologic Malignancies in Renal Transplant Recipients.
    Antunes H; Tavares-da-Silva E; Oliveira R; Carvalho J; Parada B; Bastos C; Figueiredo A
    Transplant Proc; 2018 Jun; 50(5):1348-1354. PubMed ID: 29753463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of urological cancers in renal transplant recipients: 30-year experience at the Frankfurt Transplant Center.
    Tsaur I; Karalis A; Probst M; Blaheta RA; Scheuermann EH; Gossmann J; Kachel HG; Hauser IA; Jonas D; Obermüller N
    Cancer Sci; 2010 Nov; 101(11):2430-5. PubMed ID: 20707803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
    Liu YQ; Lu J; Zhao L; Hou XF; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):605-10. PubMed ID: 26284394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microscopic hematuria in the evaluation of urologic malignancy in renal transplant recipients.
    Kim DY; Abouljoud M; Parasuraman R
    Transplant Proc; 2010 Jun; 42(5):1641-2. PubMed ID: 20620491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer in renal allograft recipients: risk factors and outcomes.
    Medani S; O'Kelly P; O'Brien KM; Mohan P; Magee C; Conlon P
    Transplant Proc; 2014 Dec; 46(10):3466-73. PubMed ID: 25498074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
    Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
    Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urological follow-up and development of cancer after renal transplantation].
    Giessing M
    Urologe A; 2015 Oct; 54(10):1393-401. PubMed ID: 26459582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo urothelial carcinoma in kidney transplant patients with end-stage aristolochic acid nephropathy in China.
    Yuan M; Shi YB; Li ZH; Xia M; Ji GZ; Xu GX; Han Y
    Transplant Proc; 2009 Jun; 41(5):1619-23. PubMed ID: 19545692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.